Sechenov School
Home › Pathology › Lung Cancer Classification

Lung Cancer Classification

*Carcinoma pulmonis*

For medical students2 min readUpdated 2026-10-10

Lung cancer is a heterogeneous group of malignant epithelial tumors. Modern classification integrates anatomic location, macroscopic growth patterns, and histogenesis, requiring immunohistochemical (IHC) staining for accurate verification.

Diagnostic basisHistology combined with immunohistochemistry (IHC)
Error riskWithout IHC, misdiagnosis rates reach up to 40%
MarkerCytokeratins are expressed in all lung cancer types
Clinical divisionSmall cell and non-small cell lung cancer

Topographic and Macroscopic Features

Based on the initial site within the respiratory tract, tumors are divided into three anatomic groups:

Depending on the direction of growth, the neoplasm may be exophytic (growing into the bronchial lumen, i.e., endobronchial) or endophytic (growing into the bronchial wall or surrounding lung tissue — exobronchial and peribronchial).

Macroscopically, tumors take various forms, including plaque-like, polypoid, nodular, branched, or nodular-branched. Cavitary forms, diffuse endobronchial growth, and a specific pneumonia-like variant also occur.

Histological Types (Classification by Histogenesis)

Microscopic structure determines the histological subtype. The main types include:

  1. Squamous cell carcinoma — varies in degree of differentiation and cellular architecture.
  2. Small cell carcinoma — divided into classic (including oat cell, lymphocyte-like, and intermediate cell variants) and combined types.
  3. Adenocarcinoma — a glandular tumor presenting in acinar, papillary, solid, and lepidic variants, as well as papillary bronchioloalveolar carcinoma and solid forms with mucin production. When well-differentiated, hematoxylin and eosin-stained sections clearly demonstrate glandular structures.
  4. Large cell carcinoma — includes giant cell and clear cell variants.
  5. Adenosquamous carcinoma.
  6. Carcinoid tumor.
  7. Bronchial gland carcinoma — e.g., adenoid cystic or mucoepidermoid carcinoma.

The Role of Microscopy and Immunohistochemistry (IHC)

Current WHO standards mandate the use of immunohistochemistry. Without IHC, the risk of misdiagnosis reaches 40%. The universal marker for all types of pulmonary carcinomas is the expression of cytokeratins. Detection of p53 protein accumulation (e.g., via immunoperoxidase staining in large cell carcinoma) is also utilized.

Routine light microscopy does not always reveal the true cellular nature:

Neuroendocrine Tumors and Clinical Classification

Tumors with neuroendocrine differentiation are now classified as a distinct group encompassing three grades of malignancy:

In clinical practice, due to differences in morphology, symptoms, chemotherapy response, and prognosis, all histological forms are grouped into two major categories:

  1. Small cell lung cancer (SCLC) — characterized by an aggressive clinical course and, along with large cell carcinoma, the poorest prognosis.
  2. Non-small cell lung cancer (NSCLC) — includes all other histological types.

Mnemonic

To remember the three grades of neuroendocrine tumors from best to worst: Typical carcinoid (high differentiation) → Atypical carcinoid (moderate) → Small cell carcinoma (low). Mnemonic: TAS.

Frequently asked questions

What are the two main groups of lung cancer in clinical practice?

Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). This distinction is critical because these groups respond very differently to chemotherapy and have different prognoses.

Why is a definitive diagnosis not made solely on light microscopy?

Light microscopy often reveals undifferentiated cells (as in large cell or small cell carcinomas). Only IHC and electron microscopy can reveal their true differentiation lineage, reducing diagnostic error by up to 40%.

Which histological types carry the most unfavorable prognosis?

The poorest prognosis is associated with small cell lung cancer and large cell lung cancer due to their high aggressiveness.

Go deeper

More topics in Pathology

Tumor Progression and MorphogenesisQuarantine Infections and Sepsis: Pathology and AutopsyPathogenesis of EdemaPurulent WoundAcquired Valvular Heart DiseaseTubulointerstitial NephritisLiver TumorsMyelodysplastic SyndromesTumor Invasion and MetastasisTypes of EdemaPutrid InflammationMorphology of Lung CancerPathology →